You are currently on the new version of our website. Access the old version .

25 Results Found

  • Review
  • Open Access
8 Citations
7,099 Views
21 Pages

Beta-Arrestins in the Treatment of Heart Failure Related to Hypertension: A Comprehensive Review

  • Ahmed Rakib,
  • Taslima Akter Eva,
  • Saad Ahmed Sami,
  • Saikat Mitra,
  • Iqbal Hossain Nafiz,
  • Ayan Das,
  • Abu Montakim Tareq,
  • Firzan Nainu,
  • Kuldeep Dhama and
  • Talha Bin Emran
  • + 1 author

Heart failure (HF) is a complicated clinical syndrome that is considered an increasingly frequent reason for hospitalization, characterized by a complex therapeutic regimen, reduced quality of life, and high morbidity. Long-standing hypertension ulti...

  • Feature Paper
  • Review
  • Open Access
9 Citations
7,815 Views
17 Pages

Beta-Arrestins and Receptor Signaling in the Vascular Endothelium

  • Claudia Lee,
  • Gayathri Viswanathan,
  • Issac Choi,
  • Chanpreet Jassal,
  • Taylor Kohlmann and
  • Sudarshan Rajagopal

23 December 2020

The vascular endothelium is the innermost layer of blood vessels and is a key regulator of vascular tone. Endothelial function is controlled by receptor signaling through G protein-coupled receptors, receptor tyrosine kinases and receptor serine-thre...

  • Article
  • Open Access
5 Citations
4,542 Views
8 Pages

Beta-Arrestin1 Levels in Mononuclear Leukocytes Support Depression Scores for Women with Premenstrual Dysphoric Disorder

  • Farzana Alam,
  • Sanket Nayyar,
  • William Richie,
  • Anthony Archibong and
  • Tultul Nayyar

Depression is very common in reproductive women particularly with premenstrual dysphoric disorder (PMDD), which is a severe form of premenstrual syndrome (PMS). Beta-arrestins were previously implicated in the pathophysiology, diagnosis and treatment...

  • Feature Paper
  • Article
  • Open Access
4 Citations
3,333 Views
21 Pages

G Protein-Dependent Activation of the PKA-Erk1/2 Pathway by the Striatal Dopamine D1/D3 Receptor Heteromer Involves Beta-Arrestin and the Tyrosine Phosphatase Shp-2

  • Federica Bono,
  • Zaira Tomasoni,
  • Veronica Mutti,
  • Giulia Sbrini,
  • Rajesh Kumar,
  • Francesca Longhena,
  • Chiara Fiorentini and
  • Cristina Missale

3 March 2023

The heteromer composed of dopamine D1 and D3 receptors (D1R–D3R) has been defined as a structure able to trigger Erk1/2 and Akt signaling in a G protein-independent, beta-arrestin 1-dependent way that is physiologically expressed in the ventral...

  • Article
  • Open Access
379 Views
13 Pages

Beta-Arrestin 1 Deficiency Enhances Host Anti-Myeloma Immunity Through T Cell Activation and Checkpoint Modulation

  • Jian Wu,
  • Xiaobei Wang,
  • Shaima Jabbar,
  • Niyant Ganesh,
  • Emily Chu,
  • Vivek Thumbigere Math,
  • Lindsay Rein and
  • Yubin Kang

27 November 2025

Beta-arrestin 1 (ARRB1) is a multifunctional adaptor protein that regulates diverse signaling pathways beyond its canonical role in G-protein-coupled receptor desensitization. While ARRB1 has been implicated in cancer progression, its role in modulat...

  • Article
  • Open Access
14 Citations
6,948 Views
11 Pages

Do Progestin-Only Contraceptives Contribute to the Risk of Developing Depression as Implied by Beta-Arrestin 1 Levels in Leukocytes? A Pilot Study

  • Keisha Smith,
  • Sanket Nayyar,
  • Tanu Rana,
  • Anthony E. Archibong,
  • Kimberly R. Looney and
  • Tultul Nayyar

We reported previously that reduction in beta-arrestin 1 (β-AR 1) protein levels in peripheral blood mononuclear leukocytes (PBMC) significantly correlated with the severity of depressive symptoms in reproductive women. In this pilot study, we u...

  • Article
  • Open Access
14 Citations
2,800 Views
29 Pages

Discovery of a Potent Highly Biased MOR Partial Agonist among Diastereomeric C9-Hydroxyalkyl-5-phenylmorphans

  • Joshua A. Lutz,
  • Agnieszka Sulima,
  • Eugene S. Gutman,
  • Eric W. Bow,
  • Dan Luo,
  • Sophia Kaska,
  • Thomas E. Prisinzano,
  • Carol A. Paronis,
  • Jack Bergman and
  • Gregory H. Imler
  • + 3 authors

15 June 2023

All possible diastereomeric C9-hydroxymethyl-, hydroxyethyl-, and hydroxypropyl-substituted 5-phenylmorphans were synthesized to explore the three-dimensional space around the C9 substituent in our search for potent MOR partial agonists. These compou...

  • Abstract
  • Open Access
1,416 Views
1 Page

Characterization of JC Polyomavirus Entry by Serotonin Receptors

  • Melissa Maginnis,
  • Colleen L. Mayberry,
  • Kashif Mehmood,
  • Matthew Parent and
  • Samuel Hess

JC polyomavirus (JCPyV) causes a lifelong persistent infection in the kidney in the majority of the population. In severely immunocompromised individuals, JCPyV can become reactivated, spread in the central nervous system, and infect glial cells, ast...

  • Article
  • Open Access
7 Citations
3,148 Views
18 Pages

Novel Cannabinoid Receptor 2 (CB2) Low Lipophilicity Agonists Produce Distinct cAMP and Arrestin Signalling Kinetics without Bias

  • Raahul Sharma,
  • Sameek Singh,
  • Zak M. Whiting,
  • Maximilian Molitor,
  • Andrea J. Vernall and
  • Natasha L. Grimsey

Cannabinoid Receptor 2 (CB2) is a promising target for treating inflammatory diseases. We designed derivatives of 3-carbamoyl-2-pyridone and 1,8-naphthyridin-2(1H)-one-3-carboxamide CB2-selective agonists with reduced lipophilicity. The new compounds...

  • Article
  • Open Access
6 Citations
3,102 Views
18 Pages

The Opioid Receptor Influences Circadian Rhythms in Human Keratinocytes through the β-Arrestin Pathway

  • Paul Bigliardi,
  • Seetanshu Junnarkar,
  • Chinmay Markale,
  • Sydney Lo,
  • Elena Bigliardi,
  • Alex Kalyuzhny,
  • Sheena Ong,
  • Ray Dunn,
  • Walter Wahli and
  • Mei Bigliardi-Qi

25 January 2024

The recent emphasis on circadian rhythmicity in critical skin cell functions related to homeostasis, regeneration and aging has shed light on the importance of the PER2 circadian clock gene as a vital antitumor gene. Furthermore, delta-opioid recepto...

  • Article
  • Open Access
9 Citations
6,733 Views
15 Pages

The Meta-Position of Phe4 in Leu-Enkephalin Regulates Potency, Selectivity, Functional Activity, and Signaling Bias at the Delta and Mu Opioid Receptors

  • Robert J. Cassell,
  • Krishna K. Sharma,
  • Hongyu Su,
  • Benjamin R. Cummins,
  • Haoyue Cui,
  • Kendall L. Mores,
  • Arryn T. Blaine,
  • Ryan A. Altman and
  • Richard M. van Rijn

12 December 2019

As tool compounds to study cardiac ischemia, the endogenous δ-opioid receptors (δOR) agonist Leu5-enkephalin and the more metabolically stable synthetic peptide (d-Ala2, d-Leu5)-enkephalin are frequently employed. However, both peptides h...

  • Review
  • Open Access
10 Citations
6,440 Views
21 Pages

The physiological and pathophysiological relevance of the angiotensin II type 1 (AT1) G protein-coupled receptor no longer needs to be proven in the cardiovascular system. The renin–angiotensin system and the AT1 receptor are the targets of several c...

  • Review
  • Open Access
1,843 Views
17 Pages

23 November 2025

This review addresses the growing concern of oral side effects, particularly dry mouth, associated with semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA) widely used for diabetes and obesity. A literature search of PubMed/MEDLINE, Sco...

  • Review
  • Open Access
15 Citations
5,249 Views
23 Pages

1 October 2021

Preeclampsia is one of the most frequent and severe complications of pregnancy. Symptoms of preeclampsia usually occur after 20 weeks of pregnancy and include hypertension and kidney dysfunction with proteinuria. Up to now, delivery of the infant has...

  • Article
  • Open Access
10 Citations
6,452 Views
15 Pages

Identification of a Novel Delta Opioid Receptor Agonist Chemotype with Potential Negative Allosteric Modulator Capabilities

  • Yazan J. Meqbil,
  • Hongyu Su,
  • Robert J. Cassell,
  • Kendall L. Mores,
  • Anna M. Gutridge,
  • Benjamin R. Cummins,
  • Lan Chen and
  • Richard M. van Rijn

29 November 2021

The δ-opioid receptor (δOR) holds great potential as a therapeutic target. Yet, clinical drug development, which has focused on δOR agonists that mimic the potent and selective tool compound SNC80 have largely failed. It has increas...

  • Review
  • Open Access
8 Citations
12,780 Views
19 Pages

Exploring the Therapeutic Potential of Mitragynine and Corynoxeine: Kratom-Derived Indole and Oxindole Alkaloids for Pain Management

  • Ahmed S. Alford,
  • Hope L. Moreno,
  • Menny M. Benjamin,
  • Cody F. Dickinson and
  • Mark T. Hamann

6 February 2025

The search for effective pain management solutions remains a critical challenge, especially amidst growing concerns over the use of conventional opioids. In the US, opioid-related mortality rates have surged to as many as 80 deaths per 100,000 people...

  • Review
  • Open Access
11 Citations
4,108 Views
7 Pages

16 April 2021

Successful pharmacological innovations that have made a difference in daily practice are rare in the world of anesthesia and sedation. After many years of research, it seems that we finally have two new drug innovations that are likely to change the...

  • Review
  • Open Access
142 Citations
11,120 Views
16 Pages

Chemerin Isoforms and Activity in Obesity

  • Christa Buechler,
  • Susanne Feder,
  • Elisabeth M. Haberl and
  • Charalampos Aslanidis

Overweight and adiposity are risk factors for several diseases, like type 2 diabetes and cancer. White adipose tissue is a major source for adipokines, comprising a diverse group of proteins exerting various functions. Chemerin is one of these protei...

  • Article
  • Open Access
2 Citations
2,832 Views
13 Pages

A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells

  • Genesio Di Muro,
  • Federica Mangili,
  • Emanuela Esposito,
  • Anna Maria Barbieri,
  • Rosa Catalano,
  • Donatella Treppiedi,
  • Giusy Marra,
  • Emma Nozza,
  • Andrea G. A. Lania and
  • Emanuele Ferrante
  • + 4 authors

16 June 2023

The molecular events underlying the variable effectiveness of dopamine receptor type 2 (DRD2) agonists in pituitary neuroendocrine tumors (PitNETs) are not known. Besides the canonical pathway induced by DRD2 coupling with Gi proteins, the β-arr...

  • Review
  • Open Access
31 Citations
8,798 Views
54 Pages

Allosteric regulation is critical for the functioning of G protein-coupled receptors (GPCRs) and their signaling pathways. Endogenous allosteric regulators of GPCRs are simple ions, various biomolecules, and protein components of GPCR signaling (G pr...

  • Article
  • Open Access
22 Citations
4,958 Views
14 Pages

Effects of Epigallocatechin Gallate (EGCG) on Urinary Bladder Urothelial Carcinoma―Next-Generation Sequencing and Bioinformatics Approaches

  • Hsiang-Ying Lee,
  • Yi-Jen Chen,
  • Wei-An Chang,
  • Wei-Ming Li,
  • Hung-Lung Ke,
  • Wen-Jeng Wu and
  • Po-Lin Kuo

1 December 2019

Background and objectives: Bladder urothelial carcinoma is the most common type of genitourinary cancer. Patients with bladder cancer may have limited treatment efficacy related to drug toxicity, resistance or adverse effects, and novel therapeutic s...

  • Article
  • Open Access
4 Citations
2,415 Views
14 Pages

Analysis of Genes Related to Invadopodia Formation and CTTN in Oral Squamous Cell Carcinoma—A Systematic Gene Expression Analysis

  • Immanuel Desel,
  • Susanne Jung,
  • Nikolai Purcz,
  • Yahya Açil,
  • Christoph Sproll,
  • Johannes Kleinheinz and
  • Sonja Sielker

18 August 2023

Successful treatment for any type of carcinoma largely depends on understanding the patterns of invasion and migration. For oral squamous cell carcinoma (OSCC), these processes are not entirely understood as of now. Invadopodia and podosomes, called...

  • Article
  • Open Access
4 Citations
3,390 Views
20 Pages

Novel Insights into Beta 2 Adrenergic Receptor Function in the rd10 Model of Retinitis Pigmentosa

  • Maurizio Cammalleri,
  • Massimo Dal Monte,
  • Rosario Amato,
  • Dominga Lapi and
  • Paola Bagnoli

9 September 2020

Background: In retinitis pigmentosa (RP), inherited rod death is followed by cone loss and blindness. Why cones die is still a matter of consideration. Here, we investigate the pathogenic role of the sympathetic transmission in the rd10 mouse model o...

  • Article
  • Open Access
15 Citations
3,706 Views
17 Pages

α-Linolenic Acid Inhibits RANKL-Induced Osteoclastogenesis In Vitro and Prevents Inflammation In Vivo

  • Yufeng Deng,
  • Weizhou Li,
  • Yingying Zhang,
  • Jingjing Li,
  • Fangting He,
  • Ke Dong,
  • Zehui Hong,
  • Ruocheng Luo and
  • Xiaofang Pei

3 February 2023

Inflammation is an important risk factor for bone-destroying diseases. Our preliminary research found that Zanthoxylum bungeanum seed oil (ZBSO) is abundant in unsaturated fatty acids and could inhibit osteoclastogenesis in receptor activator of nucl...

  • Article
  • Open Access
6 Citations
3,388 Views
21 Pages

Dysregulated Cyclic Nucleotide Metabolism in Alcohol-Associated Steatohepatitis: Implications for Novel Targeted Therapies

  • Diego Montoya-Durango,
  • Mary Nancy Walter,
  • Walter Rodriguez,
  • Yali Wang,
  • Julia H. Chariker,
  • Eric C. Rouchka,
  • Claudio Maldonado,
  • Shirish Barve,
  • Craig J. McClain and
  • Leila Gobejishvili

10 October 2023

Background: Cyclic nucleotides are second messengers, which play significant roles in numerous biological processes. Previous work has shown that cAMP and cGMP signaling regulates various pathways in liver cells, including Kupffer cells, hepatocytes,...